BLA 761471. Not in Drugs@FDA, which lists approved applications only; FDA's complete response letters name it.
As of Nov 16, 2026, BLA 761471 (AVT03) is not in Drugs@FDA, which lists approved applications; FDA has published 1 complete response letter for it.
| Letter | Product | Now |
|---|---|---|
| Dec 30, 2025 | AVT03Facility Inspections, Risk Evaluation And Mitigation Strategy Requirements, Avto3 | Unapproved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters